drugset / Trial / NCT04072328

Propofol vs. Midazolam With Propofol for Sedative Endoscopy in Patients With Previous Paradoxical Reaction to Midazolam

NCT04072328

Phase 2 Completed 30 enrolled DongGuk University
RandomizedParallel-groupDouble-blindSupportive care

Summary

This study is to compare propofol vs. midazolam with propofol for sedative endoscopy in patients with previous paradoxical reaction to midazolam. Patients who meet eligibility criteria will randomly assigned to propofol group or midazolam with propofol group. Then they will receive a sedative endoscopy with close monitoring. The primary outcome is the prevalence of paradoxical response during endoscopy.

Timeline

Start
2018-10-19
Primary completion
2020-08-10
Completion
2020-12-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule
Subject Propofol Small molecule 0.5 mg/kg

Indications

No indication recorded.